Zileuton


DB00744



General information:


Withdrawn ID: DB00744
Canonical SMILES:
Standard InChI:
Standard InChIKey:
ATC class(es): R
Molecular Formula: C11H12N2O2S
Molweight: 236.29



Withdrawal information:


Withdrawn due to drug safety reasons:No
First approved: 1996
First withdrawn: 2008
Last withdrawn: 2008



Side-effects:

Total reported cases (submitted by medical professionals) with Zileuton as primary suspect: 87


Reported final outcomes:
Hospitalization (initial or prolonged): 21
Death: 7
Disability: 3
Life-Threatening condition: 3
Congenital anomaly: 1


Reported side-effects:

Side-effect Case number
ALANINE AMINOTRANSFERASE INCREASED21
ASPARTATE AMINOTRANSFERASE INCREASED14
NAUSEA8
HEPATIC ENZYME INCREASED8
FATIGUE6
DIZZINESS6
HEADACHE5
PRURITUS4
DYSPNOEA4
BLOOD BILIRUBIN INCREASED4
BLOOD ALKALINE PHOSPHATASE INCREASED4
WHITE BLOOD CELL COUNT DECREASED3
VOMITING3
RASH3
PYREXIA3
PLATELET COUNT DECREASED3
MYOCARDIAL INFARCTION3
LIVER FUNCTION TEST ABNORMAL3
HYPERSENSITIVITY3
FEELING ABNORMAL3
Drug ineffective for unapproved indication3
DRUG INEFFECTIVE3
DIARRHOEA3
DEHYDRATION3
ATRIAL FIBRILLATION3
ASTHENIA3
ARTHRALGIA3
TRANSAMINASES INCREASED2
TACHYCARDIA2
SINUS TACHYCARDIA2
RESPIRATORY DISTRESS2
Pruritus generalised2
PALPITATIONS2
Off label use2
MYALGIA2
LETHARGY2
INTERNATIONAL NORMALISED RATIO INCREASED2
INFLUENZA LIKE ILLNESS2
Incorrect dose administered2
HYPERHIDROSIS2
HALLUCINATION2
HAEMATOCRIT DECREASED2
GAMMA-GLUTAMYLTRANSFERASE INCREASED2
DRUG HYPERSENSITIVITY2
DEPRESSION2
DECREASED APPETITE2
CONDITION AGGRAVATED2
CEREBROVASCULAR ACCIDENT2
CARDIOMEGALY2
BLOOD UREA INCREASED2
BLOOD SODIUM DECREASED2
ANXIETY2
ANGIOEDEMA2
ANAPHYLACTIC REACTION2
Abdominal pain upper2
WHITE BLOOD CELL COUNT INCREASED1
WHEEZING1
VISION BLURRED1
VIRAL INFECTION1
VENTRICULAR HYPOKINESIA1
URINARY TRACT INFECTION1
UNEVALUABLE EVENT1
Tremor1
TREATMENT FAILURE1
THROMBOCYTOPENIA1
THERAPY NON-RESPONDER1
SYNCOPE1
SUPRAVENTRICULAR TACHYCARDIA1
SUICIDAL IDEATION1
STEVENS-JOHNSON SYNDROME1
SOMNOLENCE1
SOCIAL AVOIDANT BEHAVIOUR1
Skin exfoliation1
SINUS HEADACHE1
SERUM FERRITIN INCREASED1
SEPSIS SYNDROME1
Road traffic accident1
RHINORRHOEA1
RENAL FAILURE ACUTE1
RENAL FAILURE1
RED CELL DISTRIBUTION WIDTH INCREASED1
RED BLOOD CELL COUNT DECREASED1
PULMONARY CONGESTION1
Product use issue1
Product use in unapproved indication1
PRODUCT QUALITY ISSUE1
PRODUCT FORMULATION ISSUE1
Product dose omission1
PNEUMONIA1
PHARMACEUTICAL PRODUCT COMPLAINT1
PERICARDIAL EFFUSION1
PALLOR1
PAIN IN EXTREMITY1
OVERDOSE1
OTITIS EXTERNA1
ORAL INTAKE REDUCED1
NEUTROPHIL COUNT DECREASED1
NEUTROPENIA1
MYOSITIS1
MYOCARDITIS1
MYOCARDIAL ISCHAEMIA1
MUSCLE TWITCHING1
MOOD ALTERED1
MONOCYTE COUNT INCREASED1
Migraine1
MIDDLE EAR EFFUSION1
Metabolic acidosis1
Mental status changes1
MATERNAL DRUGS AFFECTING FOETUS1
MASTOCYTOSIS1
Manufacturing product shipping issue1
MALAISE1
LYMPHOCYTE COUNT DECREASED1
Lymphatic fistula1
Lower respiratory tract infection1
LOSS OF CONSCIOUSNESS1
LIVER INJURY1
LARYNGOSPASM1
Laboratory test abnormal1
Jaw operation1
JAUNDICE CHOLESTATIC1
JAUNDICE1
INSOMNIA1
INFECTIOUS MONONUCLEOSIS1
HYPOTENSION1
Hyposmia1
HYPERTENSION1
HEPATOMEGALY1
HEPATITIS C1
HAEMOLYTIC ANAEMIA1
HAEMOGLOBIN DECREASED1
HAEMODYNAMIC INSTABILITY1
GASTROINTESTINAL HAEMORRHAGE1
GASTRITIS1
GANGRENE1
FLATULENCE1
Feeling jittery1
Fall1
EXERCISE TOLERANCE DECREASED1
EPISTAXIS1
EOSINOPHIL PERCENTAGE INCREASED1
Dysphagia1
Dysgeusia1
Dry mouth1
DRUG TOXICITY1
DILATATION VENTRICULAR1
DEEP VEIN THROMBOSIS1
DECREASED ACTIVITY1
DEATH1
CYANOSIS1
COMPLETED SUICIDE1
COAGULOPATHY1
CLOSTRIDIAL INFECTION1
CLEFT LIP1
CHRONIC OBSTRUCTIVE PULMONARY DISEASE1
CHROMATURIA1
CHOLECYSTECTOMY1
CHILLS1
CHEST PAIN1
CHEST DISCOMFORT1
Cellulitis1
CARDIOMYOPATHY1
CARDIOGENIC SHOCK1
CARDIAC FAILURE CONGESTIVE1
BUNDLE BRANCH BLOCK LEFT1
Bruxism1
Breast cancer1
Blood pressure systolic increased1
Blood pressure fluctuation1
BLOOD CREATINE PHOSPHOKINASE INCREASED1
Blood bicarbonate decreased1
BLOOD ALBUMIN DECREASED1
BACTERIAL INFECTION1
BACTERIA URINE1
ASTHMA1
ARRHYTHMIA1
ANAEMIA1
Alopecia1
AGITATION1
AGGRESSION1
Ageusia1
ADVERSE EVENT1
ACUTE CORONARY SYNDROME1
Activities of daily living impaired1
ABNORMAL DREAMS1
ABNORMAL BEHAVIOUR1
Abdominal pain lower1
ABDOMINAL PAIN1
Abdominal discomfort1
ABASIA1





Filtered ChEMBL targets:

Target UniProtKB ID Activity in nm Target Name Target gene
P09917 1100 Polyunsaturated fatty acid 5-lipoxygenase LOX5_HUMAN



Toxicity information:

Toxicity type: N/A



External links:

ChEBML: CHEMBL1743359
DrugBank: DB00744